165-302: A Three-Part, Phase 3, Randomized, Double-Blind, Placebo-Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self Administered by Adults With Phenylketo

Project: Research project

Project Details

StatusActive
Effective start/end date8/1/13 → 8/31/50

Funding

  • BioMarin Pharmaceutical Inc.